Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
Mancarella, Serena, Serino, Grazia, Dituri, Francesco, Cigliano, Antonio, Ribback, Silvia, Wang, Jingxiao, Chen, Xin, Calvisi, Diego F., Giannelli, GianluigiJournal:
Cell Death & Differentiation
DOI:
10.1038/s41418-020-0505-4
Date:
February, 2020
File:
PDF, 4.50 MB
2020